As of 2025-07-05, the Fair Value of C4 Therapeutics Inc (CCCC) is -7.27 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 1.48 USD, the upside of C4 Therapeutics Inc is -591.35%.
With the market price of 1.48 USD and our fair value calculation, C4 Therapeutics Inc (CCCC) is not a good investment. Investing in CCCC stocks now will result in a potential loss of 591.35%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -66.34 | -83.89 | -128.18 | -132.49 | -105.32 | -103.24 |
| YoY growth | -94.55% | -26.45% | -52.80% | -3.36% | 20.51% | -31.33% |
| Market Cap (mil) | 105.09 |
| P/E | |
| Forward P/E |
| EPS | -1.45 |
| Avg earnings growth rate | -31.33% |
| TTM earnings | -103.28 |